January 14, 2013 / 10:06 AM / 5 years ago

BRIEF-GlaxoSmithKline makes submission to U.S. FDA for diabetes drug

LONDON, Jan 14 (Reuters) - GlaxoSmithKline Plc : * GSK submits albiglutide bla to the US FDA * Intends to submit a regulatory application in the European union (EU) in

early 2013 * Albiglutide is not yet approved as a treatment for type 2 diabetes or any

other indication

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below